Pharmaceutical Companies
Collegium Pharmaceutical, Inc.
🇺🇸United States
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 197
- Market Cap
- $1.2B
INNOVIVA
🇫🇷France
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $1.1B
- Website
- -
Crescent Biopharma
🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 1997-01-01
- Employees
- 4
- Market Cap
- $1.1B
GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company...
Prothena
🇧🇪Belgium
- Ownership
- -
- Established
- -
- Employees
- 173
- Market Cap
- $1.1B
- Website
- -
TYRA BIOSCIENCES, INC.
🇺🇸United States
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SN?P, enables the...
Immatics
🇩🇪Germany
- Ownership
- -
- Established
- -
- Employees
- 343
- Market Cap
- $1.1B
- Website
- -
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics....
AnaptysBio
🇺🇸United States
AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural...
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $1.1B
- Website
- -
Calliditas Therapeutics, Inc.
🇺🇸United States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $1B
- Website
- -
Cullinan Therapeutics
🇺🇸United States
- Ownership
- -
- Established
- -
- Employees
- 85
- Market Cap
- $1B
- Website
- -
Cullinan Management, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA.